Clinical Trial Update: PPAR-gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing PPAR-gamma agonists in rheumatoid arthritis with cardiovascular disease; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Rheumatoid Arthritis

Drugs mentioned

• PPAR-gamma agonists

Snippet

Sponsor: University of Michigan | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-02-02